高コレステロール血症における強化された溶解性CD40Lとプロトロンボティック状態との関連:スタチン療法による効果
Francesco Cipollone1, Andrea Mezzetti, Ettore Porreca
1Center of Excellence on Aging, University of Chieti G. D'Annunzio School of Medicine, Chieti, Italy.
Circulation
|July 24, 2002
まとめ
高コレステロールは,血液凝固の問題と関連しています. 溶解性CD40リガンド (sCD40L) は,高コレステロールをこの前血栓状態と結びつけ,スタチンは両方とも減らすことができます.
科学分野:
- 心血管医学は,心臓血管医学である.
- 血液学 ヘマトロジ
- 薬理学 薬理学とは
背景:
- 高コレステロール血症は炎症とプロトロンボティック状態に関連しています.
- CD40-CD40リガンド (CD40L) 相互作用は,プロトロンボ質反応に寄与する.
- 高コレステロール血症における溶解性CD40L (sCD40L) の調査は極めて重要です.
研究 の 目的:
- 高コレステロール血症における in vivo sCD40L 発現の特徴を述べる.
- sCD40Lをプロトロンボティック状態と相関させる.
- スタチンのsCD40Lとプロトロンボティックマーカーへの影響を評価する.
主な方法:
- 研究には,80人の高コレステロール患者と80人の健康な対照群が含まれていました.
- 測定されたsCD40L,因子VIIa (FVIIa),プロトロンビン断片1+2 (F1+2),Pセレクチン,および11-デヒドロトロンボキサンB2.
- これらのマーカーに対するスタチン療法 (プラバスタチン,セリバスタチン) の効果を評価した.
主要な成果:
- 高コレステロール血症の被験者は,sCD40L,FVIIa,F1+2.2の上昇を示しました.
- sCD40Lは,総コレステロール,LDLコレステロール,血小板活性化,および血栓形成剤マーカーと相関しています.
- スタチンの治療により,sCD40L,FVIIa,F1+2レベルが著しく低下しました.
結論:
- sCD40Lは,高コレステロール血症とプロトロンボティック状態の間の分子リンクである可能性があります.
- スタチンの治療は,sCD40Lおよび関連するプロトロンボティックマーカーを効果的に減少させます.
- スタチンは,高コレステロール血症に関連した血栓塞栓リスクの管理に役立ちます.
関連する概念動画
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.8K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.8K
Cholesterol: Significance and Regulation
2.1K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
2.1K
Blood Studies for Cardiovascular System III: Serum Lipid Profile
859
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
859
Coronary Artery Disease II: Pathophysiology
1.1K
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K
Atherosclerosis I: Introduction
2.5K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.5K
Atherosclerosis III: Management
747
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
747


